Related Experiment Videos
A cell-based bar code reader for high-throughput screening of ion channel-ligand interactions.
Jon Sinclair1, Johan Pihl, Jessica Olofsson
1Department of Physical Chemistry, and Microtechnology Centre, Chalmers University of Technology, SE-412 96 Göteborg, Sweden.
Analytical Chemistry
|January 4, 2003
Summary
This study introduces a novel microfluidics-patch clamp platform for efficient screening of ion channel-ligand interactions. The system enables rapid, high-throughput characterization of weak-affinity binding, significantly accelerating drug discovery research.
Area of Science:
- Biophysics
- Pharmacology
- Microfluidics
Background:
- Ion channel-ligand interactions are crucial for cellular function and drug development.
- Characterizing weak-affinity interactions is challenging due to low binding signals and the need for extensive screening.
- Existing methods often lack the throughput and kinetic resolution required for comprehensive analysis.
Purpose of the Study:
- To develop and validate a microfluidics-patch clamp platform for high-throughput screening.
- To enable rapid characterization of weak-affinity ion channel-ligand interactions.
- To achieve kinetically resolved measurements and dose-response curves for a large number of ligands.
Main Methods:
- Integration of a microfluidic chip with multiple solution channels into an open volume.
- Utilizing a motorized scanning stage for rapid (millisecond-scale) cell movement across discrete solution zones.
- Performing patch clamp electrophysiology on scanned cells to measure ion channel activity.
Main Results:
- The platform allows for high-throughput screening of up to 10^3 ligand solutions per day.
- Kinetically resolved patch clamp measurements and dose-response curves can be obtained.
- The system is capable of characterizing weak-affinity ion channel-ligand interactions efficiently.
Conclusions:
- The developed microfluidics-patch clamp platform significantly enhances the efficiency of ion channel screening.
- This technology accelerates the characterization of weak-affinity interactions, aiding in drug discovery.
- The platform offers a powerful tool for rapid, high-throughput analysis of ligand-receptor dynamics.